Senior insider sale
Chief Operating Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$4.77M
120.41K shares
What this filing means
KNIGHT JEFF E. plans to sell 120.41K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $4.77M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/14/2026ACC: 0001950047-26-003450
Officer· Chief Operating Officer
Since Aug 2021
120.41K
Shares to sell
$4.77M
Approx. market value
20.90K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
4/14/2026
20.90KTotal acquired20.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/14/2026 | Exercise of Stock Options Cash | 20.90K | — |
| Total | 20.90K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.43K
Market value
$177.4K
4/13/2026
—Completed
Units to sell
85.16K
Market value
$3.41M
4/8/2026
—Completed
Units to sell
9.91K
Market value
$370.4K
3/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20.90K
Market value
$808.0K
4/14/2026
Total
Units
120.41K
Value
$4.77M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/13/2026 | 4.43K | $177.4K | — | Completed |
4/8/2026 | 85.16K | $3.41M | — | Completed |
3/16/2026 | 9.91K | $370.4K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 20.90K | $808.0K | NASDAQ | Planned |
| Total | 120.41K | $4.77M | ||